scholarly article | Q13442814 |
P50 | author | Usha Menon | Q55130377 |
Goska Leslie | Q56855923 | ||
Ranjit Manchanda | Q58217855 | ||
Paul D P Pharoah | Q61822938 | ||
Antonis C Antoniou | Q89766295 | ||
Jonathan P Tyrer | Q91084019 | ||
Simon A Gayther | Q91677076 | ||
Maria P Intermaggio | Q114374949 | ||
Jatinderpal K Kalsi | Q114427279 | ||
Aleksandra Gentry-Maharaj | Q30001996 | ||
Susan J. Ramus | Q45906365 | ||
P2093 | author name string | Andy Ryan | |
Andrew Lee | |||
Xin Yang | |||
Ian Jacobs | |||
Faiza Gaba | |||
P2860 | cites work | Ten-year relative survival for epithelial ovarian cancer | Q84852379 |
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types | Q28388497 | ||
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer | Q30252854 | ||
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. | Q30724410 | ||
Evaluation of Penalized and Nonpenalized Methods for Disease Prediction with Large-Scale Genetic Data | Q30992084 | ||
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction | Q34394665 | ||
Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk | Q34988777 | ||
Identification of six new susceptibility loci for invasive epithelial ovarian cancer | Q35541663 | ||
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci | Q35815958 | ||
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects | Q35848518 | ||
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer | Q36276527 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Population distribution of lifetime risk of ovarian cancer in the United States | Q36966258 | ||
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study | Q36973956 | ||
Penalized Regression and Risk Prediction in Genome-Wide Association Studies | Q37384147 | ||
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer | Q37657957 | ||
Commentary on changing the risk threshold for surgical prevention of ovarian cancer | Q39209405 | ||
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis | Q39209416 | ||
Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. | Q40467391 | ||
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Q51129805 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 546-554 | |
P577 | publication date | 2018-08-01 | |
P1433 | published in | Journal of Medical Genetics | Q14640281 |
P1476 | title | Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study | |
P478 | volume | 55 |
Q90051408 | Assessing thyroid cancer risk using polygenic risk scores |
Q91755717 | Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients |
Q92301110 | MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer |
Q90178650 | NGS analysis in Marfan syndrome spectrum: Combination of rare and common genetic variants to improve genotype-phenotype correlation analysis |
Q103027570 | Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction |
Q97524107 | Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants |
Search more.